Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma

22 Nov 2005 10:28

Standard Life Investments22 November 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Standard Life Investments Company dealt in Skyepharma PLC Class of relevant security to which the Ord GBP0.10dealings being disclosed relate (Note 2) Date of dealing 21/11/05 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 3,096,794 0.41 (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 3,096,794 0.41 (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 4,531,753 GBP0.51 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option moneypaidcall option selling, securities to which price American, date /received per purchasing, the option relates European etc. unit (Note 5) varying etc. (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. None........................................................................ .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 22/11/05 Contact name Robbie Storrie Telephone number 0131-524-2805 If a connected EFM, name of offeree/offeror with whichconnected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jun 20161:03 pmRNSForm 8.3 - Vectura Group Plc
9th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
9th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
9th Jun 201610:54 amRNSCourt sanction of Scheme of Arrangement
9th Jun 201610:51 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
9th Jun 20168:52 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 201612:25 pmRNSForm 8.5 (EPT/RI) - Skyepharma PLC Amendment
8th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
8th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 201610:24 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
8th Jun 20169:20 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 20168:32 amRNSHolding(s) in Company
7th Jun 20162:56 pmRNSTechnology License Agreement
7th Jun 20162:02 pmRNSForm 8.3 - Skyepharma Plc
7th Jun 20161:05 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
7th Jun 201611:21 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
7th Jun 20169:06 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 20163:34 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
6th Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
6th Jun 20163:09 pmRNSForm 8.3 - [Skyepharma plc]
6th Jun 20162:51 pmRNSForm 8.3 - SKYEPHARMA PLC
6th Jun 20162:14 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 20161:23 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
6th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 201610:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
6th Jun 201610:03 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 20168:35 amRNSForm 8.3 - Vectura Group plc
3rd Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
3rd Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
3rd Jun 20163:20 pmRNSForm 8.3 - Skyepharma PLC
3rd Jun 20161:45 pmRNSForm 8.3 - Skyepharma Plc
3rd Jun 20161:23 pmRNSForm 8.3 - Skyepharma Plc
3rd Jun 201611:59 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
3rd Jun 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
3rd Jun 201610:28 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
3rd Jun 20169:45 amRNSForm 8.3 - Skyepharma PLC
3rd Jun 20169:31 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
2nd Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
2nd Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
2nd Jun 20163:20 pmRNSForm 8.3 - Skyepharma PLC
2nd Jun 20161:33 pmRNSForm 8.3 - Skyepharma Plc
2nd Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
2nd Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - ve
2nd Jun 201610:32 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
2nd Jun 20169:54 amRNSForm 8.3 - Skyepharma PLC
2nd Jun 20169:10 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
1st Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
1st Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.